Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.
about
Atherosclerosis and infection: is the jury still not in?Antibiotics for secondary prevention of coronary heart diseasePrognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology studySifting the evidence-what's wrong with significance tests?Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteriesLack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control studyInterlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers.An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis.Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based reviewChlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesRole of infectious and immune factors in coronary and cerebrovascular arteriosclerosisSeroprevalence of antibodies to microorganisms known to cause arterial and myocardial damage in patients with or without coronary stenosis.Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease.Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand?Potential infectious etiologies of atherosclerosis: a multifactorial perspectiveThe relationship between infection, inflammation, and cardiovascular disease: an overview.Salivary immunoglobulins and prevalent coronary artery disease.Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases.Acute coronary syndrome and chronic infection in the Cork coronary care case-control study.Chlamydia pneumoniae in infrequently examined blood vessels.Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.The role of viruses in cardiac allograft vasculopathy.Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis.Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.Early cardiac allograft vasculopathy: are the viruses to blame?Pathogen burden, cytomegalovirus infection and inflammatory markers in the risk of premature coronary artery disease in individuals of Indian origin.Therapeutic approaches to Chlamydia infections.Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?Chlamydophila pneumoniae infection and cardiovascular diseaseLimited role for C. pneumoniae, CMV and HSV-1 in cerebral large and small vessel atherosclerosis.A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseasesStrengthening causal inference in cardiovascular epidemiology through Mendelian randomization.Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.The effect of Chlamydia pneumoniae on the expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells
P2860
Q22241306-D1981DD7-9625-46F4-ACDB-0009ADD30B53Q24201388-708F4642-5035-4B9C-B3E6-8082BC038B13Q24289043-98FCF778-774A-416B-93B1-03248671CC17Q24524896-E4DFA357-5306-428F-A09D-EF581A415876Q24791856-FF392F92-FDA9-4C91-8163-61347B7CB19CQ24802081-D6E52DFD-E6CA-4294-8C21-960970A9C74FQ24805877-FC9608F3-5EC9-4580-9530-19A74F8F37FCQ33711781-1A10C749-4904-4C90-B7D3-8148D12135A2Q33763278-319CF101-BB86-48A3-8387-DEDF3C9C2B54Q33788646-DE2095B3-A243-4DAE-8097-CB6A2B2D6433Q33805103-C90A1070-E3A3-4F6B-9646-722B9147DAC2Q33905858-CA5A357E-83FE-4D02-9507-883D99B3E427Q33942966-B3231AD7-61A0-48C5-A6AF-53D2D26A2EBEQ33999515-492E6840-CBB7-438F-917B-27CFB6531D4EQ34203352-7FC9D97D-4FAB-4D9B-9937-CEB6A3D4DF6AQ34241017-BB962FEC-03D2-4605-97D5-63F84E93B608Q34316462-7F0C87E3-E33A-40BB-8531-F7ACD5F07ED8Q34465370-2C20D989-3FBA-4D3D-8239-3BBAF11B1EEFQ34557639-88311DBB-23C1-4A9B-B5FE-A39D4092B3AEQ35121896-2A132CF8-3FEF-4A0D-BF3A-4E9CC100451EQ35523803-8A4A6722-A309-43EF-AE78-801053D5C767Q35583359-167C15E3-A892-4010-BA64-59CCC38AA5D0Q35586029-3DE150E1-769B-41D5-B8D8-3E798B1A9746Q35586164-1FA66CDA-1532-4CCE-BEEF-37C8E6E94EF1Q35671637-2AA8E143-8A32-4278-918F-EAA0E2D394F0Q35709736-A99E6BF0-4966-410B-97E3-E8AC2CFB0EA9Q35758705-647F1A41-5782-4F26-9944-A33EC0B2FC21Q35808632-C3E17468-D922-4FA1-A3C6-1819E641645FQ35871129-2A388252-8547-4B4A-A406-189FCF145B12Q36014749-CB396976-AE07-4A3C-BE4B-D8F46A870C6FQ36091407-7D309EFD-274B-4D9E-8740-1B9567CAACB9Q36283735-074822C3-E8D8-438D-9CA1-932EB00697B1Q36395715-7C1DEF09-5B65-4662-AE30-5C405F005101Q36783331-C6CCDC95-0878-4894-99F5-242845ED366DQ36961524-20DCE8C9-4FAA-476E-9BE9-CA341613267CQ37098266-F82AF3A5-1D0A-4188-B4D3-F354E5CE63CDQ37209749-5C1C4C6F-02E4-4485-A2A7-B6F8B2AE967CQ37624924-EE030DD7-EDF5-41C7-BF32-EB95701F9EFFQ37854321-7E5D743A-8393-476B-930F-9562C23A08F3Q37857559-1882F410-C9B8-400C-AC7B-974225FF3FDC
P2860
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chlamydia pneumoniae IgG titre ...... ctive study and meta-analysis.
@en
Chlamydia pneumoniae IgG titre ...... ctive study and meta-analysis.
@nl
type
label
Chlamydia pneumoniae IgG titre ...... ctive study and meta-analysis.
@en
Chlamydia pneumoniae IgG titre ...... ctive study and meta-analysis.
@nl
prefLabel
Chlamydia pneumoniae IgG titre ...... ctive study and meta-analysis.
@en
Chlamydia pneumoniae IgG titre ...... ctive study and meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
Chlamydia pneumoniae IgG titre ...... ctive study and meta-analysis.
@en
P2093
M Bernardes-Silva
P2860
P304
P356
10.1136/BMJ.321.7255.208
P407
P577
2000-07-01T00:00:00Z